Sponsor
Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Clinical research sponsor
Clinical trials
18 shownPersonalized Brain Health Service and Dementia PreventionNCT07698431 · lead sponsor · 2026-09-15
RECRUITINGLongitudinal Study for the Characterization of the Phases of Subjective Perception of Cognitive Decline and Mild Cognitive Impairment of Alzheimer's Disease.NCT03851523 · lead sponsor · 2018-02-12
RECRUITINGBrain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project ParticipantsNCT02685969 · lead sponsor · 2017-03-01
RECRUITINGPENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 CarriersNCT07730671 · lead sponsor · 2026-09-01
NOT_YET_RECRUITINGDIV-AD BARCELONA: Alzheimer's Blood-Based Biomakers for a Diverse CommunityNCT07521722 · lead sponsor · 2026-04-27
NOT_YET_RECRUITINGβ-AARC: Cohort Study for the Identification of Blood-based Biomarkers in a Population With Subjective Cognitive DeclineNCT04935372 · lead sponsor · 2021-05-25
ACTIVE_NOT_RECRUITINGALFAsleep: Exploring Cognitive and Biological Correlates of Sleep Quality and Their Potential Links With Alzheimer's DiseaseNCT04932473 · lead sponsor · 2021-01-26
COMPLETEDDetection of Cerebral Proteinopathy in Alzheimer's Disease Through Magnetic Resonance ImagingNCT03846232 · lead sponsor · 2019-02-12
COMPLETEDBarcelonaBeta Dementia Prevention Research Clinic: a Study on Risk Factors DisclosureNCT03847038 · lead sponsor · 2018-07-16
COMPLETEDMultiregional rtfMRI Neurofeedback for the Prevention of Alzheimer's Disease (NPAD)NCT03173846 · lead sponsor · 2017-05-05
COMPLETEDEarly Identification of Markers in Alzheimer's Families / ALFANCT02485730 · lead sponsor · 2016-10-25
ACTIVE_NOT_RECRUITINGControl and Intervention Programme on Alzheimer's Disease Risk FactorsNCT02772523 · lead sponsor · 2016-05-01
COMPLETEDApoe Impact Study on Brain Structure and Function, in a Population 45 to 75 Years OldNCT02198586 · lead sponsor · 2014-04-01
COMPLETEDGroup Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons CentresNCT02418806 · lead sponsor · 2014-01-01
COMPLETEDStudy for Cognitive and Genetic Characterization of a 45-65 Years Old PopulationNCT01835717 · lead sponsor · 2013-04-01
COMPLETEDExperimental Study to Validate the "Therapeutic Game" CONEM-BETANCT01652222 · lead sponsor · 2012-01-01
COMPLETEDExperimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease PatientsNCT01762618 · lead sponsor · 2012-01-01
COMPLETEDPrevention of Cognitive Decline in ApoE4 Carriers With Subjective Cognitive Decline After EGCG and a Multimodal InterventionNCT03978052 · collaborator · 2019-10-30
COMPLETEDSponsor roles
lead sponsor17
collaborator1
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.